# Immucell Corp: Form 8-K, filed Feb 1, 2023

- Company: [Immucell Corp](/companies/iccc.md) (CIK 811641)
- Form: 8-K
- Filed: 2023-02-01
- Accepted by EDGAR: Feb 1, 2023, 17:25 ET
- Period: 2023-01-24
- Accession: 0001213900-23-006754
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/811641/000121390023006754/ea172563-8k_immucell.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/811641/000121390023006754/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/811641/000121390023006754/ea172563-8k_immucell.htm

Filed Feb 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-006754. Last ingested by Listed: Nov 13, 2026, 16:08 ET. No prices; not investment advice.
